Cargando…

Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation

Detalles Bibliográficos
Autores principales:	Masset, Christophe, Ville, Simon, Garandeau, Claire, Le Borgne, Florent, Letellier, Thibaut, Cantarovich, Diego, Meurette, Aurélie, Guillot-Gueguen, Cécile, Bentoumi-Loaec, Maxime, Giral, Magali, Dantal, Jacques, Blancho, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651481/ https://www.ncbi.nlm.nih.gov/pubmed/34890687 http://dx.doi.org/10.1016/j.kint.2021.11.024

Ejemplares similares

A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients
por: Masset, Christophe, et al.
Publicado: (2022)

A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response
por: Masset, Christophe, et al.
Publicado: (2021)

Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation
por: Masset, Christophe, et al.
Publicado: (2022)

COVID-19 Severity in Kidney Transplant Recipients According to Their Postvaccination Serological Assessment
por: Masset, Christophe, et al.
Publicado: (2022)

Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients
por: Masset, Christophe, et al.
Publicado: (2023)

Early and late ANCA vasculitis relapses after kidney transplantation may have different presentations
por: Masset, Christophe, et al.
Publicado: (2022)

Incidence, Risk Factors and Outcomes of Kidney and Liver Cyst Infection in Kidney Transplant Recipient With ADPKD
por: Ronsin, Charles, et al.
Publicado: (2022)

Time-Limited Therapy with Belatacept in Kidney Transplant Recipients
por: Letellier, Thibault, et al.
Publicado: (2022)

Case Report: Long-term observations from the tacrolimus weaning randomized clinical trial depicts the challenging aspects for determination of low-immunological risk patients
por: Masset, Christophe, et al.
Publicado: (2022)

Impact of Late and Recurrent Acute Graft Pyelonephritis on Long-Term Kidney Graft Outcomes
por: Pacaud, Margaux, et al.
Publicado: (2022)

A phenotypic, transcriptional and TCR Vβ repertoire signature of CD8+ T cells define a population at-risk of long-term kidney graft dysfunction
por: Degauque, Nicolas, et al.
Publicado: (2012)

Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2021)

Sterile Pancreas Inflammation during Preservation and after Transplantation
por: Kervella, Delphine, et al.
Publicado: (2023)

Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2022)

Comparison of the risk factors effects between two populations: two alternative approaches illustrated by the analysis of first and second kidney transplant recipients
por: Trébern-Launay, Katy, et al.
Publicado: (2013)

Hyponatremia is associated with poor outcome in COVID-19
por: De Carvalho, Hugo, et al.
Publicado: (2021)

Protective Efficacy of the Calicivirus Valency of the Leucofeligen Vaccine against a Virulent Heterologous Challenge in Kittens
por: Lesbros, Cynthia, et al.
Publicado: (2013)

Induction therapy in kidney transplant recipients: Description of the practices according to the calendar period from the French multicentric DIVAT cohort
por: Boucquemont, Julie, et al.
Publicado: (2020)

Vaccination in the Era of Immunosuppression
por: Alnaimat, Fatima, et al.
Publicado: (2023)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
por: Goh, Yun Shan, et al.
Publicado: (2022)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
Publicado: (2023)

Pathogenic epitopes, heterologous immunity and vaccine design
por: Welsh, Raymond M., et al.
Publicado: (2007)

Homologous and Heterologous Covid-19 Booster Vaccinations
por: Atmar, Robert L., et al.
Publicado: (2022)

Heterologous vaccine regimens against COVID-19
por: Duarte-Salles, Talita, et al.
Publicado: (2021)

Heterologous prime boost COVID 19 vaccination
por: Launay, O., et al.
Publicado: (2022)

IMMUNOSUPPRESSIVE AND GRAFT-REJECTING ANTIBODIES IN HETEROLOGOUS ANTI-LYMPHOCYTIC SERUM
por: Cinader, B., et al.
Publicado: (1971)

Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
por: Banerjee, K, et al.
Publicado: (2012)

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
por: Mrak, Daniel, et al.
Publicado: (2022)

Editorial: Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
por: Singh, Shakti, et al.
Publicado: (2020)

Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
por: Tan, C. Sabrina, et al.
Publicado: (2022)

Heterologous COVID-19 vaccination in pregnant women: Comment
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

IMMUNOSUPPRESSION OF MICE INJECTED WITH HETEROLOGOUS ANTI-IMMUNOGLOBULIN HEAVY CHAIN ANTISERA
por: Manning, Dean D., et al.
Publicado: (1972)

A personalized follow-up of kidney transplant recipients using video conferencing based on a 1-year scoring system predictive of long term graft failure (TELEGRAFT study): protocol for a randomized controlled trial
por: Foucher, Yohann, et al.
Publicado: (2015)

Occurrence of severe COVID-19 in vaccinated transplant patients
por: Caillard, Sophie, et al.
Publicado: (2021)

Virus-Associated Nephropathies: A Narrative Review
por: Masset, Christophe, et al.
Publicado: (2022)

Heterologous effects of infant BCG vaccination: potential mechanisms of immunity
por: Butkeviciute, Egle, et al.
Publicado: (2018)

Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections
por: Agrawal, Babita
Publicado: (2019)

Efficacy of infectious bronchitis virus vaccines against heterologous challenge
por: MUNEER, M.A., et al.
Publicado: (1988)

Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development
por: Balz, Kathrin, et al.
Publicado: (2020)

Heterologous vaccine interventions: boosting immunity against future pandemics
por: Marín-Hernández, Daniela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n6g1ospvkt8mnlvkb3luinqmq0